Zobrazeno 1 - 10
of 144
pro vyhledávání: '"checkpoint immunotherapy"'
Autor:
Hung‐Wei Cheng, Wei Lee, Fei‐Ting Hsu, Yen‐Ho Lai, Shu‐Rou Huang, Chris Seh Hong Lim, Zhen‐Kai Lin, Shih‐Chao Hsu, Chih‐Sheng Chiang, Long‐Bin Jeng, Woei‐Cherng Shyu, San‐Yuan Chen
Publikováno v:
Advanced Science, Vol 11, Iss 32, Pp n/a-n/a (2024)
Abstract Photoimmunotherapy faces challenges due to insufficient intratumoral accumulation of photothermal agents and the reversion of the cancer‐immunity cycle during treatment. In this study, an anti‐PD‐L1‐immobilized magnetic gold nanohut,
Externí odkaz:
https://doaj.org/article/2ef8becf33bc4501927b66f9e70acc42
Publikováno v:
Gynecologic Oncology Reports, Vol 53, Iss , Pp 101382- (2024)
Externí odkaz:
https://doaj.org/article/6d976c6003554c32b9f9f52184ca702d
Autor:
Teresa Squicciarini, Rossella Villani, Benedetta Apollonio, Livia Fucci, Milena Zambetti, Michele Rossini, Rosamaria Pinto, Stefania Tommasi, Ileana De Roma, Sabino Strippoli, Michele Guida
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundDesmoplastic melanoma (DM) is a rare subtype of melanoma characterized by high immunogenicity which makes it particularly suitable for immune checkpoint inhibitors (ICIs) treatment.Case presentationWe report the case of a 53-year-old man wi
Externí odkaz:
https://doaj.org/article/c9c8bb77549648988e22b7388167e131
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Peripheral T-cell lymphoma (PTCL) and natural killer/T-cell lymphoma (NKTCL) are rare subtypes of non-Hodgkin’s lymphoma that are typically associated with poor treatment outcomes. Contemporary first-line treatment strategies generally involve the
Externí odkaz:
https://doaj.org/article/4e8a2f69e88744f7aa0b5b3ecb5549cc
Autor:
Alexander Muik, Isil Altintas, Friederike Gieseke, Kristina B Schoedel, Saskia M Burm, Aras Toker, Theodora W. Salcedo, Dennis Verzijl, David Eisel, Christian Grunwitz, Lena M Kranz, Mathias Vormehr, David P.E. Satijn, Mustafa Diken, Sebastian Kreiter, Kate Sasser, Tahamtan Ahmadi, Özlem Türeci, Esther C.W. Breij, Maria Jure-Kunkel, Ugur Sahin
Publikováno v:
OncoImmunology, Vol 11, Iss 1 (2022)
Immune checkpoint inhibitors (ICI) targeting the PD-1/PD-L1 axis have changed the treatment paradigm for advanced solid tumors; however, many patients experience treatment resistance. In preclinical models 4-1BB co-stimulation synergizes with ICI by
Externí odkaz:
https://doaj.org/article/c2df5e33bb4545efb02c509f371c1d5a
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Tumor-associated tertiary lymphoid structures are ectopic lymphoid aggregates that have considerable morphological, cellular, and molecular similarity to secondary lymphoid organs, particularly lymph nodes. Tumor vessels expressing peripheral node ad
Externí odkaz:
https://doaj.org/article/6a65bdb4b3ab446ca08a33a0ce67ef8b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Emma Matzen, Lars Erik Bartels, Brian Løgstrup, Stine Horskær, Christina Stilling, Frede Donskov
Publikováno v:
Cardio-Oncology, Vol 7, Iss 1, Pp 1-14 (2021)
Abstract Background Immune checkpoint inhibitor (ICI) induced myocarditis is a rare, severe, and often fatal adverse event. Evidence to guide appropriate immunosuppressive therapy is scarce. We present a case of ICI-induced myocarditis and a review o
Externí odkaz:
https://doaj.org/article/65c07c2f3ee54aadbbb72af3ea3602d7
Autor:
Xiao-Hong Xie, Li-Qiang Wang, Yin-Yin Qin, Xin-Qing Lin, Zhan-Hong Xie, Ming Liu, Jie-Xia Zhang, Ming Ouyang, Jun Liu, Ying-Ying Gu, Shi-Yue Li, Cheng-Zhi Zhou
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 15, Iss 1, Pp 1-10 (2020)
Abstract Objective NUT midline carcinoma (NMC), a rare type of squamous cell carcinoma, is genetically characterised by NUT midline carcinoma family member 1 (NUTM1) gene rearrangement. NMC can arise from the lungs; however, there is no standard for
Externí odkaz:
https://doaj.org/article/3ebf4a94265a492c81c4488f8f3ff2a6
Autor:
Nan Zheng, Joy Fleming, Peilei Hu, Jianjian Jiao, Guoqin Zhang, Ruifang Yang, Chuanyou Li, Yi Liu, Lijun Bi, Hongtai Zhang
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 1 (2022)
ABSTRACT Interest in host-directed therapies as alternatives/adjuncts to antibiotic treatment has resurged with the increasing prevalence of antibiotic-resistant tuberculosis (TB). Immunotherapies that reinvigorate immune responses by targeting immun
Externí odkaz:
https://doaj.org/article/ce59ed4564c146d4905011340e09ff56